DOC for pregnant females travelling to areas endemic to P-falciparum
**Core Concept**
Pregnant females traveling to areas endemic to Plasmodium falciparum (P-falciparum) require antimalarial prophylaxis to prevent severe malaria, which can be life-threatening. The choice of antimalarial drug is crucial during pregnancy, as some medications can be teratogenic or have adverse effects on the fetus.
**Why the Correct Answer is Right**
The preferred antimalarial drug for pregnant females traveling to areas endemic to P-falciparum is **Atovaquone-Proguanil (Malarone)**. This combination is recommended by the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) because it is effective against P-falciparum and has a favorable safety profile during pregnancy. Atovaquone and proguanil work synergistically, with atovaquone inhibiting mitochondrial DNA polymerase in the parasite, while proguanil is a dihydrofolate reductase inhibitor, blocking the synthesis of tetrahydrofolate.
**Why Each Wrong Option is Incorrect**
* **Option A:** Chloroquine is not recommended for pregnant females traveling to areas endemic to P-falciparum, as resistance to chloroquine is widespread in this region.
* **Option B:** Doxycycline is contraindicated in pregnancy due to the risk of inhibiting bone growth and causing tooth discoloration in the fetus.
* **Option C:** Mefloquine can be used in pregnancy, but it is not the preferred choice for pregnant females traveling to areas endemic to P-falciparum, as it may have a higher risk of adverse effects.
**Clinical Pearl / High-Yield Fact**
When prescribing antimalarial prophylaxis to pregnant females, it is essential to consider the gestational age, destination, and local resistance patterns to ensure the most effective and safe medication is chosen.
**Correct Answer: A. Atovaquone-Proguanil (Malarone)**